Clinical Trial

Diffusion Magnetic Resonance Imaging (dMRI) in the Early Evaluation of Brain White Matter Diseases

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 7, 2025 (before its estimated December 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
To assess the sensitivity and accuracy of diffusion magnetic resonance imaging (MRI), including diffusion-weighted imaging (DWI) metrics, in identifying early-stage changes in brain white matter related to various white matter diseases.
Trial Details
NCT Number NCT07108712
Lead Sponsor The General Authority for Teaching Hospitals and Institutes
Conditions Diffusion Magnetic Resonance Imaging, Brain White Matter Diseases
Enrollment 150 participants
Start Date 2025-05-01
Primary Completion 2025-12-01 (estimated)
Study Completion 2025-12-01 (estimated)
Updated on ClinicalTrials.gov 2025-08-07